Wake Forest Baptist Medical Center
Christopher M. Booth has not added Biography.
If you are Christopher M. Booth and would like to personalize this page please email our Author Liaison for assistance.
Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence.
Critical care medicine Jul, 2002 | Pubmed ID: 12130957
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
JAMA : the journal of the American Medical Association Jun, 2003 | Pubmed ID: 12734147
Communication in the Toronto critical care community: important lessons learned during SARS.
Critical care (London, England) Dec, 2003 | Pubmed ID: 14624673
Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest.
JAMA : the journal of the American Medical Association Feb, 2004 | Pubmed ID: 14970067
Severe acute respiratory syndrome and critical care medicine: the Toronto experience.
Critical care medicine Jan, 2005 | Pubmed ID: 15640680
Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
Journal of pain & palliative care pharmacotherapy , 2005 | Pubmed ID: 16061458
Pasteurella multocida bacteremia and tuboovarian abscess.
Obstetrics and gynecology Nov, 2005 | Pubmed ID: 16260579
Does this patient with headache have a migraine or need neuroimaging?
JAMA : the journal of the American Medical Association Sep, 2006 | Pubmed ID: 16968852
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.
Cancer May, 2007 | Pubmed ID: 17354227
Adjuvant chemotherapy for resected non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Feb, 2006 | Pubmed ID: 17409852
External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer.
BMC cancer , 2007 | Pubmed ID: 17598896
Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
European journal of cancer (Oxford, England : 1990) Jan, 2008 | Pubmed ID: 17845846
Endpoints and other considerations in phase I studies of targeted anticancer therapy: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT).
European journal of cancer (Oxford, England : 1990) Jan, 2008 | Pubmed ID: 17890079
Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
The journal of supportive oncology Sep, 2007 | Pubmed ID: 17944146
Fever and a rat bite.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses Jul, 2002 | Pubmed ID: 18159400
Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan, 2008 | Pubmed ID: 18165630
Intractable nausea in a patient with metastatic colorectal cancer following insertion of a colonic stent.
Journal of pain and symptom management Jul, 2008 | Pubmed ID: 18504088
Evolution of the randomized controlled trial in oncology over three decades.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2008 | Pubmed ID: 18955452
Translating new medical therapies into societal benefit: the role of population-based outcome studies.
JAMA : the journal of the American Medical Association Nov, 2008 | Pubmed ID: 19001630
Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
European journal of cancer (Oxford, England : 1990) Sep, 2009 | Pubmed ID: 19545996
Presentation of nonfinal results of randomized controlled trials at major oncology meetings.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2009 | Pubmed ID: 19620490
Call for clarity in the reporting of benefit associated with anticancer therapies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2009 | Pubmed ID: 19858370
Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2010 | Pubmed ID: 20567022
The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada.
Cancer Sep, 2010 | Pubmed ID: 20681012
Elements of confusion.
Journal of hospital medicine : an official publication of the Society of Hospital Medicine Nov-Dec, 2010 | Pubmed ID: 21162156
Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2010 | Pubmed ID: 21169249
Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
European journal of cancer (Oxford, England : 1990) Apr, 2011 | Pubmed ID: 21296570
Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.
JAMA : the journal of the American Medical Association Jun, 2011 | Pubmed ID: 21642686
Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Mar, 2012 | Pubmed ID: 22307012
Progression-free survival: meaningful or simply measurable?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2012 | Pubmed ID: 22370321
Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2012 | Pubmed ID: 22529258
Discordance between conclusions stated in the abstract and conclusions in the article: analysis of published randomized controlled trials of systemic therapy in lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2012 | Pubmed ID: 22649130
Achieving the achievable in muscle-invasive bladder cancer.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada Aug, 2012 | Pubmed ID: 23093533
Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based study.
Cancer Mar, 2013 | Pubmed ID: 23131995
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.
PloS one , 2013 | Pubmed ID: 23555593
Evaluation of treatment benefit: randomized controlled trials and population-based observational research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2013 | Pubmed ID: 23940222
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved